S. Rojas

发表

Comparison of SARS-CoV-2 Reverse Transcriptase Polymerase Chain Reaction and BinaxNOW Rapid Antigen Tests at a Community Site During an Omicron Surge

R. Puccinelli, Maya Petersen, G. Chamie, 2022, Annals of Internal Medicine.

The COVID-19 Symptom to Isolation Cascade in a Latinx Community: A Call to Action

E. Crawford, D. Havlir, C. M. Hoover, 2021, Open forum infectious diseases.

Evaluation of a novel community-based COVID-19 ‘Test-to-Care’ model for low-income populations

M. Petersen, D. Havlir, D. Sachdev, 2020, medRxiv.

Evaluation of a novel community-based COVID-19 ‘Test-to-Care’ model for low-income populations

M. Petersen, D. Havlir, D. Sachdev, 2020, PloS one.

Viral Load Among Vaccinated and Unvaccinated, Asymptomatic and Symptomatic Persons Infected With the SARS-CoV-2 Delta Variant

J. Derisi, D. Havlir, D. Coil, 2022, Open forum infectious diseases.

Field Performance and Public Health Response Using the BinaxNOWTM Rapid Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Antigen Detection Assay During Community-Based Testing

J. Derisi, D. Havlir, G. Chamie, 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Performance characteristics of a rapid SARS-CoV-2 antigen detection assay at a public plaza testing site in San Francisco

E. Crawford, J. Derisi, M. Petersen, 2020, medRxiv.

COVID-19 Symptoms and Duration of Rapid Antigen Test Positivity at a Community Testing and Surveillance Site During Pre-Delta, Delta, and Omicron BA.1 Periods

J. Derisi, D. Havlir, G. Chamie, 2022, JAMA network open.

No Significant Difference in Viral Load Between Vaccinated and Unvaccinated, Asymptomatic and Symptomatic Groups Infected with SARS-CoV-2 Delta Variant

J. Derisi, R. Michelmore, D. Havlir, 2021, medRxiv.

Performance Characteristics of a Rapid Severe Acute Respiratory Syndrome Coronavirus 2 Antigen Detection Assay at a Public Plaza Testing Site in San Francisco

E. Crawford, J. Derisi, D. Havlir, 2021, The Journal of infectious diseases.

Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Transmission Dynamics and Immune Responses in a Household of Vaccinated Persons

Mark S. Anderson, J. Derisi, D. Havlir, 2022, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Community Transmission of Severe Acute Respiratory Syndrome Coronavirus 2 Disproportionately Affects the Latinx Population During Shelter-in-Place in San Francisco

E. Crawford, D. Havlir, J. Batson, 2020, Clinical Infectious Diseases.

SARS-CoV-2 Community Transmission disproportionately affects Latinx population during Shelter-in-Place in San Francisco

E. Crawford, J. Derisi, M. Petersen, 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Reproducibility and implementation of a rapid, community-based COVID-19 “test and respond” model in low-income, majority-Latino communities in Northern California

D. Havlir, Arturo Durazo, K. Marson, 2022, PloS one.

Integrating Rapid Diabetes Screening Into a Latinx Focused Community-Based Low-Barrier COVID-19 Testing Program

D. Havlir, G. Chamie, C. Marquez, 2022, JAMA network open.

High Parental Vaccine Motivation at a Neighborhood-Based Vaccine and Testing Site Serving a Predominantly Latinx Community

J. Derisi, D. Havlir, G. Chamie, 2021, medRxiv.

A multi-component, community-based strategy to facilitate COVID-19 vaccine uptake among Latinx populations: From theory to practice

J. Derisi, J. Fuchs, D. Havlir, 2021, medRxiv.

Estimation of Secondary Household Attack Rates for Emergent Spike L452R Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Variants Detected by Genomic Surveillance at a Community-Based Testing Site in San Francisco

J. Derisi, M. Petersen, D. Havlir, 2021, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Estimation of secondary household attack rates for emergent SARS-CoV-2 variants detected by genomic surveillance at a community-based testing site in San Francisco

J. Derisi, M. Petersen, D. Havlir, 2021, medRxiv.

SARS-CoV-2 Community Transmission During Shelter-in-Place in San Francisco

E. Crawford, J. Derisi, M. Petersen, 2020, medRxiv.

Intermediate Risk of Choledocolithiasis: Are We on the Right Path?

L. Niño, D. Conde, S. Rojas, 2021, Annals of Medicine & Surgery.

High Likelihood of Accepting COVID-19 Vaccine in a Latinx Community at High SARS-CoV-2 Risk in San Francisco

D. Havlir, G. Chamie, C. Marquez, 2021, Open forum infectious diseases.

Field assessment of BinaxNOW antigen tests as COVID-19 treatment entry point at a community testing site in San Francisco during evolving omicron surges

J. Derisi, D. Havlir, A. Zavaleta, 2022, medRxiv.